ArticleJournal of clinical medicine2026
Meditations on Methodological Issues in Clinical Investigations of "Central Sensitization" (Jonah XII).
Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This perspective paper addresses five methodological concerns in clinical investigations across the field of pain research and the paradigm of central sensitization. The first is the conflation of the phenomenon and the measurement tool: a patient reported outcome questionnaire called "Central Sensitization Inventory" is given as an example. Second, instruments that are used for measuring central sensitization (and its severity) are not validated to measure the phenomenon of central sensitization. The third is conceptual ambiguity regarding the theoretical framework of central sensitization and nociplastic pain, perpetuating the perception of central sensitization/nociplastic pain as both a phenomenon and a mechanism at the same time. The fourth is the conflation of clinical reasoning with scientific thinking, where in the former jumping from the mechanism to the phenomenon and vice versa is natural. The fifth is terminology issues such as "central-sensitivity syndromes" and "central sensitization-associated symptoms" when referring to fibromyalgia and similar conditions. In summary, by clinician-researchers confusing empirics with theory and theory with empirics and using clinical reasoning instead of scientific thinking, central sensitization becomes an axiom instead of a paradigm to be investigated according to hypothesis-driven studies. The failure to be aware of and clearly distinguish between these cognitive frameworks can lead to flawed research designs, inappropriate interpretations of findings, groundless mechanistic conclusions, and ultimately compromised clinical decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.